Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118110

The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli.

A Cross, L Asher, M Seguin, L Yuan, N Kelly, C Hammack, J Sadoff, and P Gemski Jr

Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.

Find articles by Cross, A. in: PubMed | Google Scholar

Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.

Find articles by Asher, L. in: PubMed | Google Scholar

Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.

Find articles by Seguin, M. in: PubMed | Google Scholar

Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.

Find articles by Yuan, L. in: PubMed | Google Scholar

Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.

Find articles by Kelly, N. in: PubMed | Google Scholar

Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.

Find articles by Hammack, C. in: PubMed | Google Scholar

Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.

Find articles by Sadoff, J. in: PubMed | Google Scholar

Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.

Find articles by Gemski, P. in: PubMed | Google Scholar

Published August 1, 1995 - More info

Published in Volume 96, Issue 2 on August 1, 1995
J Clin Invest. 1995;96(2):676–686. https://doi.org/10.1172/JCI118110.
© 1995 The American Society for Clinical Investigation
Published August 1, 1995 - Version history
View PDF
Abstract

Extraintestinally invasive Escherichia coli (EC) that possess both a complete LPS and K1 capsule evade both complement-mediated bacteriolysis and neutrophil-mediated killing. Since C3H/HeJ mice that are hyporesponsive to LPS were uniquely susceptible to lethal infection with EC of this phenotype, we speculated there was an LPS-initiated host defense mechanism against this pathogenic phenotype. The LPS-normoresponsive C3H/HeN as well as the C3H/HeJ mice cleared these EC from the circulation within 4 h of intravenous administration. Whereas electron micrographs of the liver demonstrated these EC undergoing degeneration within the phagolysosomes of of both macrophages and Kupffer cells of C3H/HeN mice, these EC replicated within these cells of the C3H/HeJ mice. Restoration of anti-EC activity of C3H/HeJ mice occurred with activation of Kupffer cells and peritoneal macrophages in vivo with BCG and in vitro with IFN-gamma, but not with LPS. Pretreatment of C3H/HeJ mice with a combination of recombinant murine IL-1 and TNF-alpha also restored the killing of K1(+)-EC but did not enhance the killing of a K1(-)-EC mutant. These data are consistent with the hypothesis that (a) there is no intrinsic inability of C3H/HeJ phagocytes to kill EC, but (b) an LPS-initiated, cytokine-mediated host defense mechanism is required for such killing. These studies emphasize the importance of bacterial surface characteristics in the interaction with specific host defenses.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 676
page 676
icon of scanned page 677
page 677
icon of scanned page 678
page 678
icon of scanned page 679
page 679
icon of scanned page 680
page 680
icon of scanned page 681
page 681
icon of scanned page 682
page 682
icon of scanned page 683
page 683
icon of scanned page 684
page 684
icon of scanned page 685
page 685
icon of scanned page 686
page 686
Version history
  • Version 1 (August 1, 1995): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts